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A rise in technologies for epigenetic reprogramming of cells to pluripotency, highlights
the potential of understanding and manipulating cellular plasticity in unprecedented ways.
Increasing evidence points to shared mechanisms between cellular reprogramming and
the carcinogenic process, with the emerging possibility to harness these parallels in future
therapeutics. In this review, we present a synopsis of recent work from oncogenic viruses
which contributes to this body of knowledge, establishing a nexus between infection,
cancer, and stemness.
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INTRODUCTION
Long-standing observations have noted a number of parallels
between the homeostasis of cancer cells and that of stem cells. A
complicated picture includes the involvement of tissue stem cells
as the cells-of-origin for some cancers, a stem cell compartment
thought to maintain most tumors [commonly known as cancer
stem cells (CSCs)], as well as more recent concepts of differen-
tiated cells being reprogrammed back to pluripotency during the
carcinogenic process (Lapouge et al., 2011; Friedmann-Morvinski
et al., 2012). Several publications have shown that classic tumor
suppressors such as p53 and pRb have emerging roles in the regu-
lation of stemness (Conklin and Sage, 2009; Bonizzi et al., 2012).
In addition to that, genes generally known for their key roles in
stem cell biology, for example Nanog, appear to be deregulated
in a number of cancers (Zhang et al., 2012; Lu et al., 2013). In
the cutting edge field of reprogramming cells to pluripotency,
key players in tumor suppression have been implicated in crucial
roadblocks to the reprogramming process. While there is still a
lot to be understood, it has been proposed that understanding the
complicated relationship between stemness and cancer may hold
the key to more successful future therapies; for example target-
ing cancer stem cells may reduce the possibility of future cancer
recurrence.
Virally-induced cancers, thought to account for about 20%
of the global cancer incidence, have long been studied to enable
better understanding of the clinical manifestation of the disease
as well as for their value as models of carcinogenesis overall
(Farrell, 2002). Such cancers are attributed mainly to Hepatitis B
Virus (HBV), Hepatitis C Virus (HCV), Human Papilloma Virus
(HPV), Epstein-Barr Virus (EBV), Kaposi’s Sarcoma-associated
Herpes virus (KSHV), Human T-cell Leukemia Virus-1 (HTLV-
1), and more recently, Merkel Cell Polyoma Virus (MCPyV)
(Samanta et al., 2003; Bonilla Guerrero and Roberts, 2005; Bajaj
et al., 2007; Schiffman et al., 2007; Saha et al., 2010; Jeong et al.,
2012; Amber et al., 2013; Cook et al., 2013). These viruses encode
proteins shown to impinge on various cellular processes includ-
ing cell cycle regulation, apoptosis, cell signaling, transcriptional
regulation, and epigenetic regulation, resulting in carcinogenesis
(Saha et al., 2010). We present here evidence which implicates
oncogenic viruses in the regulation of pluripotency at various lev-
els. We argue that virus-associated cancers can serve as models to
understand the general link between cancer and stemness, as well
as the distinct role that infection plays in these cases. It should
be noted that other types of infectious agents, most notably the
leprosy bacterium and Helicobacter pylori, have also been shown
to modulate stemness-associated processes and pathways in host
cells, raising the possibility that strategies involving the manipu-
lation of cellular stemness may serve as evolutionary advantages
to pathogens (Fujii et al., 2012; Wegner, 2013). Here, we review
the available evidence for regulation of stemness by oncogenic
viruses with particular emphasis on results coming from in vivo
model systems. We also propose key questions that remain to be
addressed.
INTERACTION OF ONCOGENIC VIRUSES WITH TISSUE STEM
CELLS
Tissue stem cells and committed tissue progenitor cells des-
tined for terminal differentiation are target cells of several onco-
genic viruses. While no known oncogenic virus displays exclusive
tropism for such specific cell populations, infection of either a
stem or progenitor population may provide the opportunity of
a longer-lived cellular reservoir for viral replication. In addition,
infection of these cells might in some cases enable viruses to evade
the immune system, since tissue progenitor/stem cells might be
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immune privileged (Di Trapani et al., 2013), even though this
notion is still controversial (Tseng et al., 2010).
Gammaherpesviruses, including KSHV and its murine cousin
MHV68 and EBV infect primarily resting mature B cells.
However, these cells are short-lived and non-proliferating, which
points to the possibility that herpesviruses may also be able to
infect a progenitor, stem cell-like population of B cells, which nor-
mally gives rise to mature B cells, in order to ensure continuous
viral genome propagation and viral latency maintenance. Indeed,
there is some evidence that both human and murine gammaher-
pesviruses infect hematopoetic progenitor cells. KSHV has been
detected in immature hematopoetic cells in the bone marrow of
transplant recipients (Luppi et al., 2000; Lapouge et al., 2011) and
in hematopoietic progenitor cells in Kaposi’s sarcoma patients
(Henry et al., 1999; Friedmann-Morvinski et al., 2012), whereas
MHV68 was detected in immature splenic B cells in the mouse
(Marques et al., 2003; Collins et al., 2009). Moreover, KSHV-
infected human hematopoietic progenitor stem cells gave rise
to KSHV-infected mature human B-cells and monocytes when
transplanted in NOD/SCID mice (Wu et al., 2006). Coleman
et al. examined developing B cell infection by MHV68, a model
for gammaherpesviruses, in a fully immunocompetent mouse
host. They showed that this virus establishes long-term latency
in immature B cells in the bone marrow as well as in transi-
tional B cells in the spleen (Coleman et al., 2010). Since these
self-renewing stem cell populations of developing B cells give rise
to mature resting B cells, the authors speculate that infection of
these cell populations by herpesviruses might play a key role in
the maintenance of lifelong infection in the host.
Even though the direct involvement of Human
Cytomegalovirus (HCMV) in tumor initiation is still not
well-documented, a variety of malignancies have been associated
with HCMV infections and persistence but the association is
more widely accepted for malignant gliomas (Harkins et al., 2002;
Samanta et al., 2003; Soderberg-Naucler, 2006; Michaelis et al.,
2009). In normal brain tissue, HCMV appears to primarily target
cells in the subventricular zone (SVZ) of the brain (Perlman and
Argyle, 1992; Fritschy et al., 1996; Odeberg et al., 2007), which
is the source of local stem cells and progenitor cells within this
organ (Seri et al., 2006). Differentiation of neural precursors
into mature neurons seems to reduce susceptibility to HCMV
infection (Lokensgard et al., 1999; Cheeran et al., 2005) and
activation of PDGFR alpha (essential to the self-renewal potential
of neural stem cells) (Kofman et al., 2011) by HCMV is necessary
for successful infection (Soroceanu et al., 2008). These results
further support the possibility that the primary cell reservoir
for HCMV, at least in the brain, is the stem cell compartment
(Dziurzynski et al., 2012), and that infection of HCMV of this cell
population might be a way for the virus to successfully establish
lifelong latency in the host.
HPVs are strongly associated with a number of malignancies,
most notably cervical carcinoma (CC). Several studies have pro-
posed the existence of multiple HPV target cells within the host
epithelium. There is increasing support for the hypothesis that
stem cells of the transformation zone (TZ) of the cervical epithe-
lium are the primary site of persistent HPV infection (Lopez et al.,
2012). Given the anatomical observation that a lot of cervical
cancers are derived from the TZ, a connection between infection
of tissue stem cells and eventual carcinogenesis has been pro-
posed. The long latency period between infection with HPV and
development of cervical dysplasias supports the hypothesis that
these cells can be targets of HPV infection and serve as a vehicle
for long-term established viral latency in the cervix. Using laser
capture microdissection in a rabbit oral papillomavirus (ROPV)
model system,Maglennon et al. (2011) showed that ROPV indeed
persists in a latent state, even after immune-mediated regres-
sion of induced papillomas, and that the site of latency is a
subset of basal epithelial cells which the authors propose are
the epithelial stem cells. It should be noted that expression of
papillomavirus genes in stem cells has been shown to modu-
late their behavior in vivo and may be associated with ensuing
carcinogenesis. In a study using mice transgenic for the HPV16
oncogenes our group showed that expression of viral oncogenes
in label-retaining epithelial stem cells caused aberrant mobiliza-
tion (Michael et al., 2013). In a related study, using animals
expressing the entire HPV16 viral genome in all basal cells of
stratified epithelia, skin cancers were shown to derive from tissue
stem cells (da Silva-Diz et al., 2013).
VIRUSES GIVING RISE TO CANCER STEM CELLS
CSCs are cells within a tumor that possess stem cell proper-
ties, namely the ability to self-renew and give rise to progeny
destined for differentiation to regenerate tumor cell diversity.
Though genetic changes or oncogenic infection of an undifferen-
tiated cell is usually thought to give rise to tumor initiating cells,
tumors have been shown to originate from differentiated cells as
well (Friedmann-Morvinski et al., 2012). It has been suggested
that cellular reprogramming mediated by oncogenic viruses may
promote the formation of tumor initiating cells or CSCs. The
term “tumor initiating cells,” strictly referring to the initial cells
from which a tumorigenic transformation occurs, is used inter-
changeably in most cases, describing the ability of CSCs to fully
regenerate, or “reinitiate” the tumor.
Several reports have implicated oncogenic viruses in the gen-
eration of CSCs. Arzumanyan et al. recently showed that HBV
might induce initiation of hepatocellular carcinomas (HCC) by
activating cellular factors that promote stemness (Arzumanyan
et al., 2011). HBV encoded X antigen (HBVx), important in
the viral life cycle as well as carcinogenesis, was shown to acti-
vate stemness associated factors Oct-4, Nanog, Klf4, beta catenin,
and EpCAM in vitro. In addition, this protein was shown to
induce cell migration, sphere formation, and growth in soft
agar, all phenotypic characteristics of CSCs. These results were
confirmed in liver biopsies obtained from HCC patients, since
the above stemness associated markers were observed in the
majority of HBV associated HCCs (Arzumanyan et al., 2011).
Interestingly, microarray data fromHBV-associated HCC showed
that miR-181, recently found to contribute to tumorigenesis
(Agami, 2010), was over-expressed in hematopoietic stem cells
(HSCs) and CSCs, and was also found to be upregulated in HBx-
expressing cells and HBx-positive liver biopsies (Arzumanyan
et al., 2011) suggesting that this micro-RNA might be involved in
stemness or CSCs induction and maintenance in HBV-associated
HCCs.
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The HCV has also been implicated in induction of CSCs.
Machida et al. isolated tumor initiating stem-like cells from trans-
genic mice expressing HCV core, as well as from patients with
HCC, and showed that the Tlr4-Nanog pathway was upregulated
in these cells and was necessary for their tumorigenic prop-
erties (Machida et al., 2009, 2012). Nanog, a stem/progenitor
cell marker was further shown to be upregulated through acti-
vation of the TLR4 pathway by NS5A, a non-structural pro-
tein encoded by HCV (Machida et al., 2012). Furthermore, a
study by Ali et al. showed that infection of cultured hepatic
cells with an HCV subgenomic replicon resulted in acquisi-
tion of CSC characteristics, including expression of Lgr5, c-myc,
and DCAMKL-1 (Ali et al., 2011). A DCAMKL-1 enriched
cell population was subsequently shown to form tumors with
expression of proteins associated with metastatic potential in
athymic nude mice. Importantly, removing the HCV replicon
from these cells dramatically reduced expression of the stem
cell-associated markers. The results correlated well with analysis
of liver biopsies from HCV-infected patients, further highlight-
ing the possibility that HCV promotes a CSC-like phenotype
in vivo.
Several studies have suggested the possibility that EBV might
exert its tumorigenic properties at least in part by giving rise
to CSCs within the infected tissue. In an important study,
Kong et al. investigated the role of EBV LMP2A protein in
CSC modulation in nasopharyngeal carcinoma (NPC) cells, and
showed that expression of this protein induced cell invasion
and epithelial-mesenchymal transformation (EMT) (Kong et al.,
2010). Overexpression of LMP2A was found to enrich stem cell
like cells within the NPC tumor cell population, and increased
the number of cells that were capable of re-establishing tumors
in nude mice (Kong et al., 2010). These results were subse-
quently confirmed in NPC patient biopsies, further suggesting
that a possible mechanism of tumorigenesis in EBV-infected
tissues is the modulation of the tissue stem cell compartment
and the induction of tumor initiating cancer stem cells. A sub-
sequent study showed that, similar to LMP2A, EBV encoded
LMP1 latent membrane protein also stimulated EMT, induced a
CSC/CPC-like phenotype and enhanced the self-renewal poten-
tial in nasopharyngeal epithelial cell lines, further supporting
EBV involvement in modulation of cellular plasticity and induc-
tion of CSC cellular phenotypes (Kondo et al., 2011). This
notion is also highlighted by a more recent study (Lun et al.,
2012), which showed up-regulation of multiple stem cell mark-
ers in an EBV-positive NPC cell line with increased tumori-
genic potential and high resistance to chemotherapy. Finally, a
recent study by Port et al. demonstrated that NPC is frequently
associated with deregulation of the Hedgehog (HH) pathway,
a pathway that is associated with stem cell maintenance. In an
in vitro model of NPC, the authors showed that EBV activates
the HH pathway through induction of the SHH ligand, which
leads to increased expression of stemness-associated genes and
induction of stem cell phenotypes in these cells (Port et al.,
2013).
The long length of papillomavirus infection usually preced-
ing malignant pathologies has been proposed to relate to latency
of viral infection in tissue stem cells. Infected tissue stem cells
may serve as tumor initiating or CSC in HPV-induced CCs.
In support of this hypothesis, a study showed that the inva-
sive and metastatic potential of cervical squamous cell carcinoma
(CSCC) was correlated with cancer stem cell-associated genes,
and supported the idea that high-risk HPV might induce CSC
phenotypes in the TZ of the cervical epithelium (Liu et al.,
2010). In addition, expression of HPV E6 and E7 viral onco-
genes was shown to induce epigenetic reprogramming in human
keratinocytes, through modulation of chromatin structure and
global methylation/acetylation events involving cellular factors
that have significant role in tumorigenesis and stemness. For
example, Hyland et al. showed that E6/E7-expressing primary
human foreskin keratinocytes have elevated levels of the EZH2
methyltransferase and the KDM6A demethylase, which results
in a reduction of global H3K27 trimethylation and upregula-
tion of downstream targeted HOX genes (Hyland et al., 2011).
Reduction in trimethylation of H3K27 associated with elevated
EZH2 was also demonstrated in high-grade squamous cervi-
cal intraepithelial lesions. In a related study, McLaughlin et al.
demonstrated that repressive H3K27 trimethylation was reduced
in HPV-positive cervical lesions, and that this was a result
of E7-mediated induction of KDM6A and KDM6B demethy-
lases, which subsequently lead to significantly higher expres-
sion of homeobox genes (McLaughlin-Drubin et al., 2011).
These findings support the possibility that HPV-induced epi-
genetic reprogramming is important in viral oncogenesis, and
further highlight the commonalities between stemness and car-
cinogenesis, at least in the context of the oncogenic virus life
cycle. Further research is needed to fully understand whether
HPV-associated cancers are related to cellular reprogramming
of infected tissue stem cells or more differentiated cells. The
impact of such reprogramming on the viral life cycle also remains
unknown.
PATHWAYS TARGETED BY ONCOGENIC VIRUSES ARE
ASSOCIATED WITH STEMNESS
A number of reports have shown that classic tumor suppressors
and their pathways, notably p53 and pRb, which are long known
to be targets of oncogenic viruses (Felsani et al., 2006; Levine,
2009), have important roles in modulation of stemness.
The p53/ARF pathway is a well-established stemness repres-
sor and cells in which this pathway is inactivated can be more
efficiently reprogrammed to pluripotency (Hanna et al., 2009;
Hong et al., 2009; Kawamura et al., 2009; Li et al., 2009;
Marion et al., 2009; Utikal et al., 2009). p53 was also recently
found to induce miR-34a and miR-145, which negatively reg-
ulate stemness-associated factors (Xu et al., 2009; Jain et al.,
2012). More recently, two separate reports further highlighted the
importance of p53 in stem cell biology. Chiche et al. showed that
somatic loss of p53 resulted in higher numbers of stem/progenitor
cells in mammary epithelium (Chiche et al., 2013). Sato et al.
reported that p53 activation promoted proteosome-dependent
degradation of Nanog and differentiation of glioma stem cells
(Sato et al., 2013). It is therefore possible that p53 inactivation,
a common strategy of oncogenic viruses, may contribute posi-
tively to the viral life cycle in a way additional to the proposed
viral escape of apoptosis of infected cells.
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FIGURE 1 | Infection with oncogenic viruses highlights parallels in
cancer and stem cell biology. Oncogenic viruses modulate a variety of
cellular pathways with parallel roles in the carcinogenic process and stem
cell homeostasis. The parallels between these two processes have been
extensively documented, and increasingly well-understood in terms of
being able to reprogram cell state. However little has been done in the way
of uncovering potential roles of these pathways in infection success.
Increasing understanding of common pathways modulated may yield better
tools to prevent and treat infection, as well as ensuing carcinogenesis.
The retinoblastoma tumor suppressor (pRb) is another major
target of oncogenic viruses, since inhibition of Rb liberates the
E2F transcription factor, which stimulates entry of the cell into
the cell cycle, thus favoring viral replication. Increasing evidence
has implicated this pathway in stemness modulation, initially in
plants (Ebel et al., 2004; Wildwater et al., 2005) and subsequently
in animals (Liu et al., 2009). Accumulating evidence reinforces the
role of pRb in stem cell homeostasis (Conklin and Sage, 2009).
The pRb pathway was shown to have a critical role as a road-
block in the reprogramming of human fibroblasts to iPSCs, as
well as cell fate determination, as elegantly shown by Calo et al.
(2010). Conceivably then, like p53 inactivation, the inactivation
of pRb could promote cellular plasticity and stemness, which
in turn would confer an ideal niche for virus persistence and
latency.
There is mounting evidence supporting the recently suggested
notion that tumor suppressor pathways, traditionally key targets
of oncogenic viruses, might play a significant role in cellular plas-
ticity and modulation of stemness. Even cellular factors activated
by genetic events in virally-induced cancers such as c-myc in
Burkitt’s lymphoma, have well-described involvement in cancer
as well as stemness (Dang, 2012; Buganim et al., 2013). Therefore,
it is also not surprising that factors traditionally involved in stem-
ness and cellular plasticity are increasingly being identified as
targets of oncogenic viruses. Indeed, HCV, HBV, and EBV have
been shown to regulate a number of pluripotency and stem cell-
associated factors (Ruf et al., 1999; Machida et al., 2009; Ali et al.,
2011; Lun et al., 2012). In addition, telomerase activation and
telomere maintenance are important in both cancer and stem-
ness, and it is therefore not surprising that oncogenic viruses
evolved to regulate these processes. Most, if not all, tumor viruses,
including the oncogenic retrovirus HTLV-1, induce transcrip-
tional activation of telomerase (Kuhlmann et al., 2007; Bellon
and Nicot, 2008), and EBV and HPV are also known to regulate
telomerase post-transcriptionally.
DISCUSSION
Oncogenic viruses cause cancer after long-term infection of their
natural niche. These viruses interfere with signaling pathways
that are important in a number of major cellular processes
including cell proliferation and cell division, apoptosis, and cell
differentiation. Accumulating evidence suggests that oncogenic
viruses may also manipulate cellular stemness in various ways.
Stem cells or progenitor cells are targets of infection and nor-
mal cell homeostasis is disrupted as a result. Moreover, pathways
that are traditionally associated with self-renewal and lineage-
commitment have been shown to be transcriptionally regulated
by viral oncoproteins. Regulation of such pathways, and of onco-
genic pathways now understood to play key roles in stemness,
may lead to cellular reprogramming. Whether regulation of stem-
ness is necessary for ensuing carcinogenesis, or whether it has any
impact on the viral life cycle, has not been conclusively addressed.
However, it is conceivable that infection of tissue stem cells might
positively affect the viral life cycle, especially in terms of estab-
lishing a successful chronic infection (Figure 1). It should also
be noted that regulation of innate immunity and inflammation,
also known to be linked to carcinogenesis, is now beginning to be
linked to stemness as well (e.g., TLR4-Nanog, TLR3) (Machida
et al., 2009; Lee et al., 2012). Additional studies are necessary in
order to fully investigate this notion, especially in the context of
in vivo infection models. As we continue to explore the parallels
between cellular stemness and the carcinogenic process, onco-
genic viruses continue to serve as excellent paradigms with plenty
to teach.
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